Form 8-K - Current report:
SEC Accession No. 0000950170-25-051219
Filing Date
2025-04-04
Accepted
2025-04-04 17:00:09
Documents
12
Period of Report
2025-04-02
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fgen-20250402.htm   iXBRL 8-K 49307
2 EX-3.1 fgen-ex3_1.htm EX-3.1 200268
  Complete submission text file 0000950170-25-051219.txt   399950

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fgen-20250402.xsd EX-101.SCH 25824
14 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20250402_htm.xml XML 4877
Mailing Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 25815614
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)